News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Moberg Pharma AB (Formerly known as Moberg Derma) Announces Prospectus Regarding Admission To Trading Of New Shares


6/18/2014 10:59:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Not for announcement, publication or distribution, directly or indirectly, in or into the U.S., Canada, Japan, Hong Kong, New Zealand, South Africa or Australia. The prospectus regarding the admission to trading of newly issued shares in Moberg Pharma AB (publ)(STO:MOB) is now available on the company’s website www.mobergpharma.se and in the company’s offices, at Gustavslundsvägen 42, 167 51 Bromma. Documents incorporated by reference in the prospectus are also available in accordance with the above.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES